Finals to December 2024 are in line with revenue and EBITDA revealed at the January trading update, with adj dil EPS ahead of expectations. Revenue of £97.9m appears to indicate reported revenue retreat vs £101.3m vs FY24, but that fails to take into account the delayed last effects of the COVID order book wash through from FY20-22 into FY23 – a normalised revenue progression indicates 8.2% underlying organic growth in FY24. Recurring revenue nudged up from 74% to 75% of group revenue, and 79% o ....
